CLINICAL_TRIALS
withdrawal
· 2016-12-06
Clinical Trial Update: China Refractory Obsessive-Compulsive Disorder Deep Brain Stimulation Study [Phase 2, Phase 3]
Summary
A China-based deep brain stimulation trial for refractory obsessive-compulsive disorder (Phase 2/3) has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ruijin Hospital | Conditions: Obsessive Compulsive Disorder | Phase 2, Phase 3 | Status: WITHDRAWN